A prescription injectable medication used to improve blood sugar (glucose) control in adults with type 2 diabetes. It works to lower blood glucose levels. It provides long-acting basal insulin and enhances insulin secretion, and slows gastric emptying.Indications:- Improves glycemic control in adults with type 2 diabetes when combined with diet and exercise.- Suitable for patients not adequately controlled with basal insulin or GLP-1 receptor agonists alone.Main Active Ingredients:- Insulin Glargine 100 U/mL.- Lixisenatide 33 mcg/mL.Precautions:- Monitor blood glucose levels regularly to avoid hypoglycemia.- Do not use in patients with diabetic ketoacidosis.- Inform your doctor if pregnant, breastfeeding, or having pancreas, heart, or gastrointestinal issues.- Avoid use with other GLP-1 receptor agonists.- Rotate injection sites to reduce lipodystrophy and localized skin reactions.Side Effects:- Hypoglycemia (low blood sugar).- Nausea, vomiting, diarrhea.- Upper respiratory tract infection, headache.- Severe allergic reactions (rare).- Pancreatitis (rare).- Heart failure risk if combined with TZDs.Drug-Drug Interactions:- May interact with other antidiabetic medications (insulin, sulfonylureas).- Oral contraceptives may have reduced efficacy if taken close to injection.- Antibiotics or acetaminophen should be taken at least 1 hour before injection.- Inform your healthcare provider about all prescription, OTC, and herbal medications.

- Inject subcutaneously once daily within 1 hour before the first meal.
- Do not exceed 60 units per day.
- Use only clear, colorless solution; do not shake vigorously.
- Change injection sites daily to avoid skin lumps or irritation.
- The dosage as directed by a healthcare professional.

• Blood glucose monitor

Insulin Glargine 100 Units/Ml, Lixisenatide 33 Mcg/Ml, With Zinc Chloride, Metacresol, Glycerin, Water For Injection, And Methionine.